The emergence of microfluidic immunosensors has provided a promising tool for improving clinical diagnoses. We developed an electrochemical immunoassay for the simultaneous detection of cardiac troponin I (cTnI) and C-reactive protein (CRP), based on microfluidic chips.
Cardiovascular disease is one of the leading causes of death in the world. Cardiac troponin I (cTnI) 4 is used to diagnose acute myocardial infarction (1 ) . C-reactive protein (CRP) is used in the risk assessment of coronary events (2 ) and in optimizing statin therapy in the primary and secondary prevention settings of cardiovascular disease (3, 4 ) . These tests are usually measured individually in the clinical laboratory using a variety of immunotechniques.
Recently, microfluidic technology was applied in various situations, including cellular analysis, biomimetic systems, clinical diagnosis, and immunoassays (5, 6 ) . Considerable effort is being spent to overcome the limitations of conventional bioassay through the development of immunosensors that can provide continuous, in situ, and rapid measurement of biomolecular activity (7) (8) (9) . Microfluidic systems have attracted attention because of intrinsic features such as miniaturization that make it suitable for point-of-care testing (10 -13 ) . More importantly, the microfluidic immunosensors are amenable to integration with other microanalytical functions and elements such as valves, mixers, and detectors that enable the simultaneous measurement of multiple analytes (14 ) .
A series of quantum dots (QDs) such as CdS, PbS, CuS, and ZnS has been developed for the detection of multiple proteins and DNA target analytes (15) (16) (17) (18) . QDs have advantages over conventional dye molecules such as tunable fluorescence signatures, narrow emission spectra, brighter emission, and good photostability. QD-based electrochemical bioassay has received particular attention because of inherent miniaturization, low detection limits, low cost, and low power re-quirements (19 ) . In a microfluidic system, the integration of electrochemical detection is simple, effective, and enables a rapid measurement of multi-targets on the basis of voltage modification (20, 21 ) .
A simple approach for in situ synthesis of poly-(dimethylsiloxane) (PDMS)-gold nanoparticle (GNP) composite film was proposed based on the reductive property of PDMS (22 ) . Such a technique allows the effective integration of several functions, such as microreactors, in a microfluidic system. Combined with its other features, such as biocompatibility and easy fabrication, PDMS has gradually become a promising material to perform simultaneous multi-target analysis.
Here we describe an approach for the simultaneous detection of dual biomarkers in a PDMS-GNP composite microfluidic system based on the integration of a novel electrochemical immunosensor. The CdTe and ZnSe QDs were used as the media, conjugated with two different antibodies. After immunoassay, square-wave anodic stripping voltammetry (SWASV) was used to detect metal ions dissolving from the QDs in a microchannel via flow injection mode. By using the indirect method, the dual biomarkers could be detected and quantified. cTnI and CRP were chosen as the two biomarkers for this proof of principle exercise.
Materials and Methods

REAGENTS
CRP, anti-CRP, cTnI, and anti-cTnI were purchased from Beijing Biosynthesis Biotechnology. BSA was purchased from Nanjing KeyGen Biotech. Acetic acid (HAc) and sodium acetate (NaAc) were purchased from Sigma-Aldrich. Chloroauric acid (HAuCl 4 ) was obtained from Shanghai Experiment Reagent. Sylgard 184 PDMS was obtained from Dow Corning. Human serum samples were obtained from the First Affiliated Hospital of Nanjing Medical University and used immediately. All other chemicals were of analytical grade and were used without further purification. Ultrapure fresh water obtained from a Millipore water purification system (MilliQ, specific resistivity Ͼ18 mol/L⍀cm Ϫ1 , S. A. Molsheim) was used in all runs. All solutions used in the detection were filtered through a 0.22-m cellulose acetate filter (Shanghai Bandao Factory).
APPARATUS
We used a microchip with a cross-type channel combined with an end-channel electrochemical detector. The detector was located in the detection reservoir and consisted of an Ag/AgCl reference electrode, a Pt wire counter electrode, and a homemade carbon fiber working electrode (i.d. 7 m) (23 ) . Electrochemical detection was performed with a CHI 842b electrochemical workstation (CHI).
The laboratory-made power supply had a voltage ranging from 0 to 5000 V and 0 to Ϫ5000 V. The current could be monitored graphically in real time. Electrical contact with the solutions was achieved by placing platinum wires into the reservoirs. Fig. 1 shows the nature of the microchip and the device.
PREPARATION OF CdTe AND ZnSe QDs AND BIOCONJUGATION
OF QDs WITH ANTIBODIES
CdTe and ZnSe QDs were synthesized according to a previously reported procedure (24 -27 ) . The obtained solution with the QDs was further purified by ultrafiltration (28 ) . The purified water-soluble QDs have a bright fluorescence and stability in the buffer solution. The conjugation procedure for the QDs with antibodies (Ab 2 ) was similar to that in previous reports (28 -31 ) .
FABRICATION OF IN SITU SYNTHESIS OF PDMS-GNPS COMPOSITE MICROREACTORS
PDMS-GNP composite films were fabricated using a previously reported procedure (22 ) . PDMS monomer and the curing agent (Sylgard 184, Dow Corning) were mixed in the proportion 1:0.06 and cured at 80°C for 90 min in a series of holes (i.d. 4 mm), as shown in Fig.  2 , and then sealed with another flat composite film to produce the microreactors. Then 0.5% (m/v) HAuCl 4 aqueous solution was added into the holes of the resulting native PDMS microreactors and incubated at 37°C for 48 h to obtain the PDMS-GNPs composite microchip. Fig. 2A shows the schematic diagram of this procedure. Fig. 2 shows how the GNPs are synthesized in situ on the native PDMS to form PDMS-GNP composite microreactors ( Fig. 2A) , the antibodies (Ab 1 ) are adsorbed on GNPs in the microreactor (Fig. 2B) , the antigens (Ag) are captured by the corresponding antibodies (Fig. 2C) , the fabricated QDs-Ab 2 are combined with the antigens (Fig. 2D) , and finally the antigens are detected by the measurement of the corresponding metals after the dissolution of QDs (Fig. 2E) with stripping voltammetry.
ANTIBODY IMMOBILIZATION AND IMMUNOREACTION PROCEDURE
The selected amount of Ab 1 (anti-cTnI, anti-CRP) was immobilized onto the PDMS-GNP microreactor cells and incubated overnight at 4°C in a moisture chamber. After incubation, the microreactor cells were rinsed with PBS containing 0.05% Tween to remove physically adsorbed Ab 1 and dried with nitrogen gas. The microreactor cells were then blocked with 5% BSA solution for 1 h at 37°C and washed with PBS containing 0.05% Tween and dried with nitrogen gas. Ab 1 -modified cells were then incubated with 30 L of antigen samples (cTnI, CRP) for 50 min at 37°C. Then 30 L QD-Ab 2 solution (CdTe QD-anti-cTnI, ZnSe QDanti-CRP) was added into the cells. After a 50-min incubation at 37°C, the cells were washed thoroughly with PBS containing 0.05% Tween to remove nonspecifically bound QD conjugations and dried with nitrogen gas. 
Simultaneous Dual Cardiac Markers Microchip Immunoassay
FOURIER-TRANSFORMED INFRARED ABSORPTION BY TOTAL ATTENUATED REFLECTION (ATR-FT-IR)
A flat piece of PDMS was prepared as described in Fig.  2 to create the PDMS-GNP composite film. Fouriertransformed infrared absorption by total attenuated reflection was performed for the Ab 1 -coated surface of PDMS-GNP composite film using a Perkin-Elmer PE-1800 Fourier-transformed infrared absorption (FT-IR) spectrometer.
MICROCHANNEL FLOW INJECTION STRIPPING VOLTAMMETRIC
ANALYSIS
The QDs remaining on the surface of microreactors were dissolved by adding 30 L HNO 3 solution (0.10 mol/L) to each cell and letting it stand for 2 h. The solution containing the dissolved metal ions was then transferred into 270 L acetate buffer (0.10 mol/L) at pH 4.5. The amount and identity of the dissolved metal ions were determined by stripping voltammetry. The carbon fiber working electrode was placed at the end of the microchannel. A squarewave anodic stripping voltammogram was recorded. The sample solution passed through the microchannel with a driving voltage as shown in Fig. 3 . The three-electrode system consisted of a working electrode, an Ag/AgCl reference electrode, and a platinum wire counter electrode. After the electrodeposition had proceeded for 120 s with a 1200-V driving voltage at Ϫ1.2-V deposition potential, the solution was kept quiescent for 10 s, and stripping from Ϫ0.6 V to Ϫ1.2 V was performed by using a square-wave voltammetry with 4-mV potential steps, 25-mV amplitude, and 25-Hz frequency.
Results and Discussion
Two QDs conjugating with two different antibodies (CdTe QD-anti-cTnI, ZnSe QD-anti-CRP) were used in the simultaneous detection of two proteins (cTnI, CRP). By using different QDs, each protein yields a distinct voltammetric peak, for which position and size reflects the identity and concentration, respectively, of the corresponding antigen (17 ) .
STRIPPING VOLTAMMETRIC ANALYSIS ON THE MICROCHIP
SWASV was selected for the detection of the cadmium and zinc ions from the dissolved QDs, because it could combine the amplification feature of stripping voltammetry with the speed advantage of square-wave scanning (32 ) . In our approach, SWASV was integrated with the microfluidic system, in which the microchannel was applied as the vessel to deliver the metal ions driven by electrophoresis for preconcentration.
In this approach, deposition time and driving voltage were the two main factors. High driving voltage and long deposition time could induce more samples to deposit to the electrode surface. However, the excessive driving voltage added at the two ends of the microchannel might bring air bubbles that lead to solution transmission. In addition, since the area of carbon fiber electrode was limited, the excess deposition of ions could not induce the signal increase. Accordingly, Ϫ1.2 V, 120 s, and 1200 V were chosen as the optimal conditions for the deposition potential, deposition time, and driving voltage, respectively.
The effect of injection volume of the flow injection mode was also of importance in the microchannel. Solution driving was controlled by the coeffects of electrokinetic driving and electroosmotic driving after adding high voltage to the two ends of the microchannel.
The injection volume (Q) of electrokinetic injection in capillary can be calculated according to the following equation.
where e is the electrophoretic mobility of the sample, EOF is the electroosmotic mobility, r is the capillary radius, V is the voltage, L is the length of the effective microchannel, t is the preconcentration time, and C is the component concentration. The actual injection volume in the channel is approximately 440 nL after 120 s preconcentration, and the apparent mobility of the sample in the microchannel is approximately 3.7 nL/s.
Traditional voltammetric detection requires at least a microliter sample volume, whereas in our experiment, when using the microchannel as the vessel with no adding reaction vessel, only a nanoliter sample volume was needed. Solution flow in the channel corresponded to stirring mode in traditional voltammetric detection (33 ) . Therefore, the microchannel was used not only as the vessel to decrease solution, but also to realize the accumulation via the solution flow in the channel. The use of the external three-electrode system allows comprehensive contact with solutions. This result decreased electrode pollution and benefited electrode renewal.
CHARACTERIZATION OF THE MICROCHIP
The film with gold nanoparticles is an ideal substrate for the use in antigens, enzymes, and other biomolecules (34 -39 ) . Therefore, the fabrication of PDMS-GNP composite microchips can be used in immunoassay, biosensors, and enzyme reactors. Fouriertransformed infrared absorption by total attenuated reflection spectra was used to characterize the protein adsorption on the microchip. Fig. 4 shows the spectra from the native PDMS (Fig. 4A) and Ab 1 absorbed on PDMS-GNPs composite film (Fig. 4B) . The band in antibody at 1670 cm Ϫ1 shown in the inset of Fig. 4 corresponds to the asymmetric stretching of COO Ϫ . A broad band was observed in the 3200-to 3650-cm -1 range. The effect of the PDMS-GNP composite film on the adsorption of Ab 1 was also considered. Different Ab 1 concentrations were used for detecting the antigen (0.2 g/L) and corresponding QD-Ab 2 . The resulting data (Fig. 5) were used to quantify the saturating concentration of Ab 1 on the PDMS-GNP composite film. To achieve saturation of Ab 1 , we selected 0.05 g/L as the experimental Ab 1 concentration. Fig. 6 shows the analysis of the biomarkers for cTnI (Fig. 6A) and CRP (Fig. 6B) . The electrochemical signals were directly proportional to the amount of target analytes. Fig. 6A shows the typical SWASV voltammogram. A mixture of two metal ions yielded sharp and baseline-resolved peaks at Ϫ0.775 V for Cd 2ϩ and Ϫ1.05 V for Zn 2ϩ (vs Ag/AgCl), which was corresponding to the QD-conjugated antibody of CdTe QD-anti-cTnI and ZnSe QD-anti-CRP. The peaks were well defined, and the intensity was linearly proportional to the concentration of the corresponding target biomarker. The resulting calibration plots were linear, as shown in Fig. 6B , with correlation coefficients of [cTnI] and [CRP] of 0.9966 (Fig. 6A ) and 0.9978 (Fig. 6B) , respectively. The response plot was linear over the 0.01-50 g/L range for cTnI and 0.5-200 g/L range for CRP. The detection limit was approximately 0.004 g/L for cTnI and approximately 0.22 g/L for CRP (approximately 5 amol for cTnI and approximately 307 amol for CRP in a 30-L sample). Low detection limits were expected in connection with long deposition time. The low detection limits was coupled with excellent selectivity and the absence of nonspecific adsorption effects. Such results could be attributed to the fact that PDMS-GNP composite microreactors provided a biocompatible interface that had stereoattaching sites and an ideal and effective platform for the immobilization of Ab 1 . The stereo structures of gold nanoparticles also offer a thriving niche for binding more antibody-conjugated QDs. This nano-protein-nano complex could effectively enhance the capability of capturing the target protein, which may positively improve the detection sensitivity. In particular, the immunoassay was based on QDs labels as electrochemical signal by stripping analysis. The low detection limit of stripping analysis, a powerful technique for trace metal measurement, is attributed to the preconcentration step, during which the target metals are accumulated onto the working electrode. As shown in Fig. 6A , the detection of Zn 2ϩ was not as good as that of Cd 2ϩ . However, this result can be improved by surface modification of the carbon fiber electrode. A mixture containing 50 g/L cTnI and CRP that was measured six times yielded reproducibility, as reflected by relative standard deviations (CV), for Cd and Zn peaks, of 6.3% and 7.8%, respectively. Additionally, the wide flat baseline (e.g., between the Cd and Zn peaks or before Cd) indicates the possibility of simultaneously measuring more proteins.
SANDWICH IMMUNOASSAY ON THE MICROCHIP
APPLICATION TO SERUM ANALYSIS
The measurement of cTnI and CRP in 20 clinical serum samples using this approach was compared with an ELISA and a turbidimetric immunoassay [see Fig. 1 in the Data Supplement that accompanies the online version of this article at http://www.clinchem.org/ content/vol56/issue11]. The comparison study data demonstrate acceptable performance of the proposed method.
In conclusion, we have demonstrated a proof of principle for an approach to simultaneously measure cTnI and CRP using electrochemical analysis on microfluidic chips. Specifically, the microchannel was used as the vessel so that it only needed a microliter sample volume. The detection limits for squarewave anodic stripping voltammetry could reach attomoles. It could theoretically be further improved by surface modification of the carbon fiber electrode. This SWASV flow injection detection in the microchannel for the detection of metal ions could be expanded to environmental monitoring, heavy metal ion-based nanoparticles, and nanoparticlebased biosystems. 
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